Yayın:
Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors

Sadeleştirilmiş öğe sayfası
dc.contributor.authorMehlika Dilek Altıntop
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorBelgin Sever
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorGülşen Akalın Çiftçi
dc.contributor.authorÇiftçi, Gülşen Akalın
dc.contributor.authorGülhan Turan‐Zitouni
dc.contributor.authorTuran‐Zitouni, Gülhan
dc.contributor.authorZafer Asım Kaplancıklı
dc.contributor.authorKAPLANCIKLI, ZAFER ASIM
dc.contributor.authorAhmet Özdemır
dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.orcid0000-0002-8159-663X
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0001-5098-8967
dc.contributor.orcid0000-0002-9513-7661
dc.contributor.orcid0000-0003-2252-0923
dc.contributor.orcid0000-0003-0280-5550
dc.date.accessioned2025-11-13T09:17:06Z
dc.date.issued2018-06-22
dc.identifier.doi10.1016/j.ejmech.2018.06.049
dc.identifier.endpage924
dc.identifier.issn0223-5234
dc.identifier.openalexW2811382258
dc.identifier.pubmed29966916
dc.identifier.scopus2-s2.0-85049299276
dc.identifier.startpage905
dc.identifier.urihttps://hdl.handle.net/11421/1008
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2018.06.049
dc.identifier.volume155
dc.identifier.wos000441856300072
dc.language.isoen
dc.relation.ispartofEuropean Journal of Medicinal Chemistry
dc.rightsopenAccess
dc.subjectChemistry
dc.subjectProtein kinase B
dc.subjectCell culture
dc.subjectApoptosis
dc.subjectBiochemistry
dc.subjectBiology
dc.titleDesign, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5048968214
local.authorid.openalexA5040352588
local.authorid.openalexA5045943806
local.authorid.openalexA5046700148
local.authorid.openalexA5060247565
local.authorid.openalexA5100651829

Dosyalar

Koleksiyonlar

Publications